- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: REGN475/SAR164877
Total 31 results
-
Regeneron PharmaceuticalsTerminatedBack PainUnited States
-
Regeneron PharmaceuticalsTerminatedAbdominal Pain UpperUnited States
-
Regeneron PharmaceuticalsSanofiCompleted
-
Regeneron PharmaceuticalsSanofiCompletedAdvanced Solid MalignanciesUnited States
-
Regeneron PharmaceuticalsCompleted
-
Regeneron PharmaceuticalsWithdrawnFibrodyplasia Ossificans Progressiva (FOP) | Heterotopic Ossification (HO)
-
Regeneron PharmaceuticalsCompletedHealthy VolunteersBelgium
-
Regeneron PharmaceuticalsWithdrawnSporadic Inclusion Body Myositis
-
Regeneron PharmaceuticalsCompletedFibrodysplasia Ossificans ProgressivaUnited States, Spain, Canada, France, Poland, Italy, Netherlands, United Kingdom
-
Regeneron PharmaceuticalsCompleted
-
Regeneron PharmaceuticalsCompletedConjunctivitis | Allergic RhinitisUnited States, Belgium, Canada, Denmark, Germany
-
Regeneron PharmaceuticalsSanofiCompleted
-
Regeneron PharmaceuticalsTeva Pharmaceutical Industries, Ltd.TerminatedOsteoarthritis | Chronic Low Back PainUnited States
-
Regeneron PharmaceuticalsCompletedHealthy VolunteersUnited States
-
Regeneron PharmaceuticalsSanofiWithdrawn
-
Regeneron PharmaceuticalsCompletedOsteoarthritis, Knee | Osteoarthritis, HipUnited States
-
Regeneron PharmaceuticalsSanofiCompletedA Study of the Safety and Efficacy of REGN475(SAR164877) in Patients With Osteoarthritis of the KneeOsteoarthritis of the KneeUnited States
-
Regeneron PharmaceuticalsTeva Pharmaceutical Industries, Ltd.CompletedOsteoarthritis of the Knee or HipUnited States, Bulgaria, Chile, Colombia, Denmark, Estonia, Germany, Hong Kong, Hungary, Italy, Lithuania, Mexico, Peru, Poland, Romania, Russian Federation, South Africa, Spain, Sweden, Ukraine, United Kingdom
-
Regeneron PharmaceuticalsTeva Pharmaceutical Industries, Ltd.CompletedOsteoarthritis, Knee | Osteoarthritis, HipUnited States, Poland, United Kingdom
-
Regeneron PharmaceuticalsCompletedLow Back PainUnited States, Poland, Canada, Hungary, Denmark, Estonia, Czechia
-
Regeneron PharmaceuticalsRecruitingFibrodysplasia Ossificans ProgressivaJapan, United States, Korea, Republic of, Spain, France, Australia, United Kingdom, China, Poland, Malaysia, Italy, Finland, Hong Kong, South Africa, Chile, Brazil, Netherlands, Colombia
-
Regeneron PharmaceuticalsTeva Pharmaceutical Industries, Ltd.CompletedOsteoarthritis, Knee | Osteoarthritis, HipUnited States
-
Regeneron PharmaceuticalsTerminatedCarcinoma, Non-Small-Cell LungUnited States
-
Regeneron PharmaceuticalsRecruitingAdvanced Solid TumorsUnited States, Turkey
-
Regeneron PharmaceuticalsDepartment of Health and Human ServicesCompletedHealthy VolunteersUnited States
-
Regeneron PharmaceuticalsTeva Pharmaceutical Industries, Ltd.TerminatedOsteoarthritis, Knee | Osteoarthritis, HipUnited States, Poland, United Kingdom
-
Regeneron PharmaceuticalsTeva Pharmaceutical Industries, Ltd.CompletedOsteoarthritis, Knee | Osteoarthritis, HipUnited States, Poland, Hungary, Spain, Germany, United Kingdom, Denmark, Lithuania, Romania, Russian Federation, South Africa, Ukraine
-
Regeneron PharmaceuticalsTeva Pharmaceutical Industries, Ltd.CompletedOsteoarthritis, Knee | Osteoarthritis, HipUnited States
-
Eli Lilly and CompanyCompletedOsteoporosisUnited States, Canada
-
Regeneron PharmaceuticalsAvailable
-
Regeneron PharmaceuticalsActive, not recruiting